European Approval Makes Atara’s Ebvallo™ First Allogeneic T-Cell Therapy Approved Worldwide
Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD Represents First Approval of an Allogeneic
International Congress Registration
International congress on the application of new technologies of stem cells and genetics in Personalized Medicine In the beautiful Kish Island It will be held
crispr cas9 gene editing used cut out mutation early study
System shows proof-of-concept effects in reducing production of toxic molecules A CRISPR/Cas9 gene editing system can be used to remove the repeat expansion in the C9ORF72 gene,
Cancer Vaccine to Simultaneously Kill and Prevent Brain Cancer Developed
Summary: A new stem cell therapy approach eliminates established brain tumors and provides long-term immunity, training the immune system to prevent cancer from returning. Source: Brigham and
Personalized Molecular Therapy
Personalized molecular therapy is a contemporary field of medicine whose primary goal is to target the molecular mechanisms involved in disease pathogenesis and development. Nowadays,
Personalized Cell Therapy
Personalized cell therapy is a modern treatment that uses the patient’s viable cells or grafts to regenerate damaged organs. A personalized cell therapy cycle consists
